Archives

Roman Kniazev

One Shot at a Cure: How Roman Kniazev Is Winning the Biotech Survival Game

Roman Kniazev, CEO of Nuravax, has emerged as one of biotech's most effective fundraisers, securing a mix of competitive grants and private investments to advance innovative drug programs. Kniazev shared some practical insights on navigating biotech's complex fundraising and clinical development landscape.


23andMe Sells DNA Database to Regeneron in £256m Deal: Is Your Data Safe?

23andMe's sale to Regeneron transfers genetic data for drug development, raising privacy issues and concerns over consumer control and benefits.

Levi's Sells Iconic Dockers Brand to Authentic, Eyes Global Expansion

Levi's sells Dockers to Authentic Brands for $311 million to focus on denim, global growth, and core brand strategy.

Japan's Agriculture Minister Quits After Controversial Rice Comment

Japan's agriculture minister resigns after controversial rice comment amid rising food prices and public backlash.


Latest News

Elon Musk Pulls Back on Political Donations After Backing Trump
Elon Musk says he's cutting back on political donations after backing Trump with over $250 million in 2024.
Walmart CFO Signals Consumer Price Increases Coming in Late May
Walmart CFO warns shoppers may see higher prices by late May due to rising import tariffs.
Vanguard’s $40 Million Mutual Fund Deal Tossed by Judge Due
A judge tosses Vanguard's $40M investor settlement, citing overlap with an earlier SEC payout.
CBS News CEO Exits as Trump Lawsuit Settlement Talks Heat
CBS News CEO Wendy McMahon resigns amid legal battles and settlement talks with Donald Trump.
Regeneron Buys 23andMe After Bankruptcy, Promises Data Privacy Safeguards
Regeneron acquires 23andMe for $256M after bankruptcy, pledging to protect customer genetic data.
Elon Musk Joins Microsoft AI Event Despite Suing the Company
Elon Musk partners with Microsoft to host Grok AI on Azure, despite an ongoing lawsuit.
ZeroGPT
With AI-generated content becoming more common, it's getting harder to tell if something was written by a human or a machine. This is where ZeroGPT comes in. ZeroGPT is an AI detector tool designed to identify whether a piece of text was written by a human or generated by artificial intelligence.
Capital One Credit Card
The merger, announced in February 2024, has left customers wondering about changes to their accounts and financial products.
Stock Market
In 2025, online casinos are more than just gaming—they're tech powerhouses attracting investors, driving economic growth, and leading digital innovation.
Target Boycott Leaders to Protest on George Floyd Anniversary Over
Black faith leaders plan protests at Target on May 25, demanding the return of DEI initiatives.
  48 49 50 51 52 53 54 55 56